Biolife solutions to report third quarter 2024 financial results and business update on november 12, 2024

Bothell, wash. , oct. 31, 2024 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading developer and supplier of bioproduction products and services for the cell and gene therapies ("cgt") and broader biopharma markets, today announced the company's third quarter 2024 financial results will be released after market close on tuesday, november 12, 2024.
BLFS Ratings Summary
BLFS Quant Ranking